Jefferies LLC

Alphamab Oncology, a Chinese biopharmaceutical company, kicked off pre-deal investor education for a potential $250m IPO on Monday after gaining approval to list from the Hong Kong Stock Exchange.

Chinese biopharmaceutical firm I-Mab has set the ball rolling for a potential $100m Nasdaq IPO, having filed a prospectus with the US regulator on Tuesday.

SDCL Energy Efficiency Income Trust, the London-listed fund focused on energy efficiency projects, has raised £100m as it prepares to ramp up its investment activities.

Globalworth Real Estate Investments, the London-listed real estate investment trust focused on commercial properties in Romania and Poland, is preparing to raise up to €276.45m of fresh equity to finance its bulging pipeline of acquisitions.

A £443.7m block trade in Avast, the London-listed Czech cyber security firm, on Tuesday night, has given confidence to equity bankers that deals can still be done this autumn, even when political volatility appears severe.

The US corporate bond market continued to crank out investment grade deals despite fears of a global recession battering risk assets this week.

Voyager Air Ltd, the Guernsey-domiciled aircraft leasing firm, has cancelled its $200m IPO on the London Stock Exchange, blaming difficult market conditions.

Wanda Sports kicks off IPO bookbuild — CloudMinds starts gauging interest for $500m float — NetEase's Youdao eyes US listing — Alphamab Oncology gears up for HK deal

Chinese biopharmaceutical company Alphamab Oncology is planning to start sounding out investors for its Hong Kong IPO later this week, according to a source close to the transaction.

CLSA’s former chief executive Jonathan Slone has joined Jefferies Group as chairman of Asia, adding to the growing exodus of staff from the Citic Securities-backed bank to the US firm.

The financial institutions bond market is showing no signs of fatigue in Europe, with US financial services company Jefferies Group preferring euros over dollars for the first time since 2014 on Friday. There was some debate about fair value for its €500m deal, given the lack of outstanding comparables.

By offering top level relationships and niche sector coverage, Jefferies has become a pillar of stability in corporate finance, writes David Rothnie. Now it is playing a more active role in public company takeovers.